<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04321733</url>
  </required_header>
  <id_info>
    <org_study_id>Bacteriology of Tonsillitis</org_study_id>
    <nct_id>NCT04321733</nct_id>
  </id_info>
  <brief_title>Bacteriological Study of Acute Follicular Tonsillitis</brief_title>
  <official_title>Bacteriological Study of Acute Follicular Tonsillitis in Patients Attending the ENT Outpatient Clinic of Assiut University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to answer the following questions :-

        1. Is there an actual failure rate in tonsillitis treatment with amoxicillin clavulanate ?
           If yes,

        2. What is (are) the possible reason(s) to explain it in our locality ?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tonsillitis is one of the most common diseases in the throat that occurs in the younger age
      group .

      The predominant bacteria causing tonsillitis are group A b-haemolytic streptococci (GABHS),
      which are highly susceptible to the penicillin group of antibiotics.

      It has been reported in the literature that the rate of penicillin failure has consistently
      increased from about 7% in the 1950s to almost 40% in the 2000s.

      Authors propose many reasons to explain such failure rates e.g. the coexistence of
      oropharyngeal beta-lactamase producing bacteria .

      Although there were no documented reports, it was observed that there are rising reports of
      failure in treatment of acute follicular tonsillitis by amoxicillin clavulanate.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The sensitivity of the isolated organism to amoxicillin clavulanate according to culture and sensitivity test</measure>
    <time_frame>Baseline</time_frame>
    <description>throat swabs that will be taken from the tonsillar exudate, placed in sterile bottles and brought to the laboratory for Bacteriological culture of the organism and Antibiotic sensitivity tests will be done for the isolated organism(s).</description>
  </primary_outcome>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Acute Follicular Tonsillitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin Clavulanate</intervention_name>
    <description>Intravenous drug intake of our drug.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute follicular tonsillitis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        patients with acute follicular tonsillitis neither younger than five years nor older than
        60 years old.

        Exclusion Criteria:

          1. Other causes of tonsillitis that do not cause suppuration .

          2. Age below five , and above 60 years .

          3. Patients who received antibiotic one week before presentation .

          4. Immune compromised patients .

          5. Patients with quinsy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mena W Dous, Principal investigator</last_name>
    <phone>+201277170022</phone>
    <email>Dr_manoon@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alaa K Abd El Haleem, Professor of Otolaryngology</last_name>
    <phone>+201005534200</phone>
  </overall_contact_backup>
  <link>
    <url>http://www.researchgate.net/publication/285386865_Clinical_and_Bacteriological_Study_of_Acute_Tonsillitis</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Brook I. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis. Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1501-8. Epub 2007 Jul 17. Review.</citation>
    <PMID>17644191</PMID>
  </reference>
  <reference>
    <citation>Casey JR, Pichichero ME. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):39S-45S. Epub 2007 Feb 9. Review.</citation>
    <PMID>17292576</PMID>
  </reference>
  <reference>
    <citation>Sela S, Barzilai A. Why do we fail with penicillin in the treatment of group A streptococcus infections? Ann Med. 1999 Oct;31(5):303-7. Review.</citation>
    <PMID>10574501</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mena Wahby Dous Hana</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

